ANI Pharmaceuticals Inc share price logo

ANI Pharmaceuticals Inc

NASDAQ: ANIP

Small Cap

$80.88

+1.38

(+1.74%)

as on

ANI Pharmaceuticals Inc Stock Performance

as on May 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $78.11
    $81.48
    downward going graph

    3.42%

    Downside

    0.74%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $56.71
    $99.50
    downward going graph

    29.88%

    Downside

    23.02%

    Upside

    downward going graph

ANI Pharmaceuticals Inc share price movements today

Previous Close
$79.50
Open
$78.16
Volume
271.4K
Day's Low - High
$78.11 - $81.48
52 Week Low - High
$56.71 - $99.50

ANI Pharmaceuticals Inc Historical Returns

1 Month Return
+ 1.55 %
3 Month Return
+ 2.77 %
1 Year Return
+ 31.69 %
3 Year Return
+ 90.78 %
5 Year Return
+ 126.75 %

ANI Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check ANI Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

9.4151

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.87%

PE Ratio (TTM)

20.13

Industry PE ratio

9.185384615384615

PEG Ratio

1.06

EBITDA

187.6M

Revenue (TTM)

923.7M

Profit Margin

9.98%

Return On Equity TTM

18.32%

ANI Pharmaceuticals Inc Stock Valuation

Track how ANI Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

ANI Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (8.83x)

September 30, 2021

Industry (9.19x)

May 14, 2026

Today (20.13x)

May 14, 2026

Highest (35.39x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 20.13x

ANI Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ANI Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.8B126.75%20.139.98%
BUY$24.7BNA21.5140.62%
HOLD$19.7B7.31%NA-2.04%
BUY$40.3BNA18.215.11%
BUY$32.1B-55.34%12.5728.04%

Stock Returns calculator for ANI Pharmaceuticals Inc Stock including INR - Dollar returns

The ANI Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ANI Pharmaceuticals Inc investment value today

Current value as on today

₹1,50,361

Returns

₹50,361

(+50.36%)

Returns from ANI Pharmaceuticals Inc Stock

₹33,974 (+33.97%)

Dollar Impact

₹16,387 (+16.39%)

Analyst Recommendation on ANI Pharmaceuticals Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for ANI Pharmaceuticals Inc. Average target price of $109.88

ANI Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on ANI Pharmaceuticals Inc.

What analysts predicted

26.39%UPSIDE

Target Price

$109.88

Current Price

$80.88

Analyzed by

11 Analysts

Target

$109.88

ANI Pharmaceuticals Inc target price $109.88, a slight upside of 26.39% compared to current price of $80.88. According to 11 analysts rating.

Indian Investors' Interest in ANI Pharmaceuticals Inc Stock

Search interest for ANI Pharmaceuticals Inc Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

ANI Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
131
137
138
148
190
197
211
227
247
237
Gross Profit
78
88
80
85
110
124
136
111
237
122
Operating Income
6
20
5
-20
-4
26
13
22
48
38
EBITDA
21
44
17
-13
14
48
39
61
76
59
Interest Expense
5
4
4
2
6
8
8
4
22
3
Depreciation
15
14
14
15
22
22
23
22
22
-
Income Before Tax
0
25
-2
-31
-13
19
10
33
31
40
Income Tax Expense
0
7
-
-7
-3
4
1
7
3
10
Net Income
1
18
-2
-24
-10
15
8
24
27
29
Net Profit Margin
0.88%
13.25%
-1.66%
-16.29%
-5.39%
7.95%
4.04%
10.59%
11.13%
12.42%

ANI Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
128
176
201
206
208
216
316
486
614
883
Gross Profit
79
97
128
143
121
115
177
305
364
450
Operating Income
20
28
35
16
-16
-39
-35
46
0
81
EBITDA
56
57
69
60
28
3
25
106
63
207
Interest Expense
11
12
14
12
9
11
28
26
17
20
Depreciation
-
27
33
44
44
47
56
60
67
91
Income Before Tax
8
16
20
3
-25
-56
-62
19
-22
95
Income Tax Expense
4
17
4
-2
-3
-13
-14
1
-3
17
Net Income
3
-1
15
6
-22
-42
-47
18
-18
78
Net Profit Margin
3.06%
-0.61%
7.69%
2.95%
-10.82%
-19.71%
-15.14%
3.86%
-3.01%
8.87%

ANI Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
18
-2
-24
-10
15
8
26
27
27
Operating Cash Flow
18
17
12
15
34
75
44
30
58
Investing Cash Flow
8
-4
-398
-10
-19
-6
-6
-1
-11
Financing Cash Flow
-19
-1
291
-4
-9
-1
6
-4
-21
Change in Cash
7
11
-95
0
4
67
44
22
25

ANI Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
15
6
-22
-42
-47
18
-18
78
Operating Cash Flow
39
67
45
15
3
-31
118
64
185
Investing Cash Flow
-107
-27
-27
-68
-105
-15
-18
-404
-34
Financing Cash Flow
72
-27
1
-1
194
-5
67
264
-9
Change in Cash
3
11
19
-54
92
-52
167
-76
140

Global Institutional Holdings in ANI Pharmaceuticals Inc

Funds
Holdings
State Street Corp
3.2%
Soleus Capital Management, L.P.
2.14%
Deep Track Capital, LP
2.1%
JPMorgan Chase & Co
1.13%
Arrowstreet Capital Limited Partnership
2.08%

ANI Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 04 May

    Mon, 07:24 PM

    -

    ANI Pharmaceuticals has a +7.81% Earnings ESP and Zacks Rank #3, with earnings report scheduled for May 8.

Insights on ANI Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 8.54M → 29.49M (in $), with an average increase of 27.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ANIP has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. has given 103.9% return, outperforming this stock by 72.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 247.06M → 237.46M (in $), with an average decrease of 3.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ANIP stock has moved down by -5.3%

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
OrganisationANI Pharmaceuticals Inc
Headquarters210 Main Street West, Baudette, MN, United States, 56623
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Nikhil Lalwani
E-voting on sharesClick here to vote

Key Management of ANI Pharmaceuticals Inc

Name

Title

Mr. Christopher K. Mutz

Senior VP & Head of Rare Disease

Mr. Muthusamy Shanmugam MS R.Ph.

Head of R&D, COO of New Jersey Operations & Director

Mr. Chad Gassert

Senior Vice President of Corporate Development & Strategy

Mr. Stephen P. Carey

Senior VP of Finance & CFO

Ms. Meredith W. Cook J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Ori Gutwerg

Senior Vice President of Generics

Ms. Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Ms. Krista L. Davis

Senior VP & Chief Human Resources Officer

Dr. Mary Pao M.D., Ph.D.

Chief Medical Officer

Mr. Nikhil Lalwani

President, CEO & Director

FAQs

What is ANI Pharmaceuticals Inc share price today?

ANI Pharmaceuticals Inc share price today is $80.88 as on at the close of the market. ANI Pharmaceuticals Inc share today touched a day high of $81.48 and a low of $78.11.

What is the 52 week high and 52 week low for ANI Pharmaceuticals Inc share?

ANI Pharmaceuticals Inc share touched a 52 week high of $99.5 on and a 52 week low of $56.71 on . ANI Pharmaceuticals Inc stock price today i.e. is closed at $80.88,which is 18.71% down from its 52 week high and 42.62% up from its 52 week low.

What is ANI Pharmaceuticals Inc's market capitalisation today?

ANI Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in ANI Pharmaceuticals Inc Stock (ANIP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ANI Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ANI Pharmaceuticals Inc Shares that will get you 0.0185 shares as per ANI Pharmaceuticals Inc share price of $80.88 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy ANI Pharmaceuticals Inc Stock (ANIP) from India?

Indian investors can start investing in ANI Pharmaceuticals Inc (ANIP) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in ANI Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on ANI Pharmaceuticals Inc share’s latest price of $80.88 as on May 14, 2026 at 8:45 am IST, you will get 0.1236 shares of ANI Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that ANI Pharmaceuticals Inc has given to Indian investors in the last 5 years?

ANI Pharmaceuticals Inc stock has given 126.75% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?